What’s the Most Weight You Can Lose on Ozempic?

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide represents one of the most effective weight loss medications available today, with FDA-approved formulations demonstrating consistent results across diverse patient populations. Most people using semaglutide experience meaningful weight reduction within the first 8–12 weeks of treatment, though the total amount you lose depends on multiple personal and biological factors. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, allowing you to access this therapy without insurance or membership fees.

Average Weight Loss Results on Semaglutide Therapy

Clinical trial data from the STEP program showed that patients using semaglutide injections lost between 9.2% and 17.4% of their starting body weight, depending on the dose and study duration. In the STEP 3 trial specifically, participants averaged a 17.4% reduction in body weight over 68 weeks—meaning someone starting at 250 pounds could expect to lose approximately 43 pounds on average. Real-world outcomes from compounding pharmacies and specialized weight loss clinics often align closely with these clinical figures, though individual variation is significant.

The timeline for weight loss follows a predictable pattern: most patients notice appetite suppression and reduced food intake within days to weeks, with visible weight reduction typically beginning in week 2–4 of consistent treatment. By month three, many people have lost 5–10% of their baseline weight, providing early motivation for lifestyle adherence. Continued steady loss of 1–2 pounds per week is common during the active treatment phase, though this rate may slow as you approach your target weight.

Factors That Determine Your Maximum Weight Loss Potential

Your genetic predisposition plays a critical role in how your body responds to semaglutide—certain variants in the GLP1R gene (like rs6923761) and the MC4R gene (like rs17782313) influence both your appetite sensitivity and metabolic rate. The Precision Peptide Genetic Test from PlexusDx maps 14 metabolic pathways and 150+ genetic insights related to weight regulation, helping identify which patients are likely to be strong responders. Understanding your genetic profile allows you and your provider to set realistic expectations and potentially adjust dosing strategy for optimal outcomes.

Lifestyle factors including diet quality, physical activity level, sleep consistency, and stress management directly influence how much weight you ultimately lose. Semaglutide works best when combined with a whole-foods-focused diet and regular movement—the medication reduces hunger signals and cravings, but you must still choose nutritious options. Starting dose also matters: while your dose may increase over time, your price won't with PlexusDx's flat-rate pricing model, meaning you can titrate safely to your optimal therapeutic level.

Comparing Semaglutide to Other GLP-1 Weight Loss Options

Semaglutide and tirzepatide are the two most researched GLP-1 medications for weight loss, with tirzepatide (a GLP-1 and GIP dual agonist) generally producing slightly larger average weight reductions of 20–22% in clinical trials. However, semaglutide remains highly effective, better tolerated by some patients, and has a longer clinical track record dating back to its diabetes approval in 2017. PlexusDx offers both compounded semaglutide injections (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and tirzepatide injections (at $289/mo month-to-month, or from $249/mo on the 6-month plan), allowing personalized selection based on your medical history, genetic profile, and response goals.

The choice between these medications should factor in your individual genetic markers, previous medication responses, and gastrointestinal tolerance. Some people experience fewer nausea side effects with semaglutide at lower doses, while others respond better to the dual-pathway stimulation of tirzepatide. PlexusDx's approach supports both options with transparent, flat monthly pricing across all dose levels—ensuring cost never becomes a barrier to finding your optimal therapy.

Realistic Expectations for Sustained Weight Loss

Most semaglutide users reach a plateau in weight loss after 6–12 months of continuous treatment, at which point further reduction requires either slight dose adjustments, intensified lifestyle changes, or consideration of combination therapy like GLP-Squared (semaglutide plus tirzepatide). The weight you've lost by this plateau typically represents 12–18% of your starting body weight for average responders, though exceptional responders may achieve 20%+ reduction. Maintaining this loss long-term is the critical next phase—studies show that stopping semaglutide gradually leads to weight regain, so ongoing treatment is essential for durable results.

The sustainability of your weight loss increases dramatically when you build new eating habits, establish consistent exercise routines, and address emotional eating patterns during your active treatment period. Many patients report that semaglutide 'resets' their relationship with food, making it easier to maintain healthy choices even if they eventually taper the medication under medical supervision. PlexusDx supports this journey with ongoing access to compounded semaglutide at predictable, affordable pricing, so cost doesn't force an unwanted gap in treatment continuity.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight can I realistically expect to lose on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How quickly will I see weight loss results on semaglutide?

You'll likely notice reduced appetite within days to one week, with measurable weight loss appearing in weeks 2–4 of consistent treatment. By week 12, most patients have lost 5–10% of their baseline weight. Continued steady weight loss of 1–2 pounds per week is typical during months 2–6 of therapy.

What if I'm a poor responder to semaglutide—are there alternatives?

Genetic testing through PlexusDx can help identify whether tirzepatide or dual-compound therapy (GLP-Squared) might work better for your metabolic profile. Approximately 20% of patients show stronger responses to tirzepatide's dual GLP-1/GIP action. PlexusDx offers both options with flat monthly pricing at $289/mo month-to-month, or from $249/mo on the 6-month plan.

Will my weight come back if I stop semaglutide?

Research shows gradual weight regain occurs after stopping semaglutide, though many patients retain 50–70% of their lost weight long-term if they've maintained lifestyle changes. This is why ongoing treatment is recommended for sustained results. PlexusDx's flat pricing model makes continuous access affordable without dose-based cost increases.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.